BioNJ Announces Lineup for Virtual BioPartnering Conference

TRENTON, NJ (September 2, 2020) – BioNJ’s Tenth Annual BioPartnering Conference scheduled for Tuesday, October 6, and Wednesday, October 7, will bring hundreds of life sciences professionals from the Northeast and beyond together for networking, 1:1 partnering meetings, company presentations, posters, exhibits and plenary sessions. “We’re thrilled to once again present BioNJ’s BioPartnering Conference in concert with J.P. Morgan and Johnson &… Read the full article


BioNJ’s First Two Entrepreneurship Fellows Launch Exciting Careers

BioNJ’s First Two Entrepreneurship Fellows Launch Exciting Careers  Trenton, NJ (August 14, 2020) – BioNJ, the life sciences trade association for New Jersey, congratulates Irina Katz, PharmD, and Paul Oyefesobi, PharmD, RPh, the first two Fellows in BioNJ’s Entrepreneurship Fellowship Program, on successfully completing their fellowships and landing exciting positions in the industry. Irina Katz just began a position as a Clinical Research Scientist at BioNJ Member Insmed… Read the full article


Breaking News from BIO Digital 2020: BIO/TEConomy’s Report Confirms New Jersey’s Continued National Industry Leadership

TRENTON, NJ (June 8, 2020) – New Jersey is being touted as a national leader at the BIO Digital International Convention taking place this week. Released earlier today, BIO/TEConomy’s report,  ” The Bioscience Economy: Propelling Life-Saving Treatments, Supporting State & Local Communities ,” analyzes the bioscience industry’s economic footprint across the nation. The study details each of the biosciences subsectors including, biotechnology, pharmaceuticals, health care… Read the full article


BioNJ Elects New Board Trustees and Advisors

TRENTON, N.J. (May 4, 2020) –  BioNJ, the life sciences trade association for New Jersey, announced the election of two new Board Members and four new Advisors. Newly elected Board Members are  Mitzi Conners,  Executive Director & Head of Operations, MRL Business Development & Licensing, Merck & Co. and Leigh Anne Leas, North America Head of Public Policy, Novartis.  Newly appointed Advisors are  Kathleen… Read the full article


BioNJ’s 27th Annual Dinner Meeting & Innovation Celebration Honors New Jersey’s Innovators and the Patients Who Inspire Them

TRENTON, NJ (February 11, 2020) – New Jersey’s life sciences community came out for BioNJ’s 27th Annual Dinner Meeting & Innovation Celebration that took place last Thursday, February 6, at the Hilton East Brunswick. Dedicated to “Patients… Because they just can’t wait,” the inspirational evening honored the unprecedented medical innovation coming from the Garden State… Read the full article



BioNJ’s C-Suite Summit – Speakers and Agenda

TRENTON, NJ (September 11, 2019) – BioNJ has released the final speaker roster for its Seventh Annual C-Suite Summit, taking place Friday, November 8, 2019 at the Bridgewater Marriott.  The C-Suite Summit brings together more than 200 life sciences executives representing a wide breadth of companies from early to late stage, public and private, and revenue and pre-revenue for a… Read the full article


BioNJ Announces Selection of Second Fellow in BioNJ’s Entrepreneurship Fellowship Program

Trenton, NJ (July 26, 2019) – BioNJ, the life sciences trade association for New Jersey, is pleased to announce Paul Oyefesobi, Ohio State University, College of Pharmacy (Class of 2019), as the second fellow in BioNJ’s Entrepreneurship Fellowship Program. BioNJ’s Entrepreneurship Fellowship Program was created in 2018 to mentor, develop and train life sciences entrepreneurs in New Jersey to encourage the… Read the full article


BioNJ Unveils New “Protecting Medical Innovation” Web Portal

TRENTON, NJ (June 27, 2019) – BioNJ, New Jersey’s life sciences trade association, today unveiled its new “Protecting Medical Innovation: Ensuring Patient Access to Cures” web portal at www.BioNJ.org/Protect-Medical-Innovation, launched in concert with a full digital marketing campaign. BioNJ’s campaign focuses on the value of medical innovation and the threat that one-size-fits-all approaches to drug value assessments, such… Read the full article


BioNJ Releases White Paper: “A Framework for Demonstrating the Value of Medical Innovation”

Trenton, NJ – June 5, 2019 – BioNJ, the trade association for New Jersey’s life sciences industry, today released “A Framework for Demonstrating the Value of Medical Innovation,” a white paper authored by Shailja Dixit, M.D., M.S., M.P.H., President & Founder, ApexBio, and Robert Goldberg, Ph.D., Vice President & Founder, Center for Medicine in the Public Interest, that outlines a… Read the full article